Authors
Latest:
Using and Sequencing EGFR Exon 20-Targeted Therapies for NSCLCXiuning Le, MD, PhD, discusses counseling patients on the use of amivantamab-vmjw and mobocertinib and the sequencing of these drugs for patients with non–small cell lung cancer and an EGFR exon 20 insertion.
Latest:
Rationale, Data, and Future of Using Ide-Cel CAR T-Cell TherapyLarry D. Anderson, Jr, MD, PhD, discusses the rationale behind using chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma, data from the KarMMa trial, and other trials investigating this treatment.
Latest:
Perspectives on the Future on Myelofibrosis TreatmentStephen T. Oh, MD, PhD, concludes with thoughts on the future treatment landscape for myelofibrosis.
Latest:
Liquid Biopsies Become More Common for Gastric and GI CancersJoseph Kim, MD, discusses the utility of liquid biopsies in patients with gastric or gastrointestinal cancer at the 2020 GI Cancers Symposium held by the American Society of Clinical Oncology.
Latest:
Exploring the CLL14 Trial in Untreated CLL After 4 Years of Follow-upOthman Al-Sawaf, MD, discusses the use of venetoclax plus obinutuzumab in patients with untreated chronic lymphocytic leukemia on the CLL14 study.
Latest:
DFS vs OS Primary Endpoints in KEYNOTE 564Scott Tykodi, MD, PhD, discusses using DFS as a primary end point in trials, as well as the usage of biomarkers.
Latest:
Future Landscape of BPDCN ManagementDr. Schiller will discuss the limitations of current treatment options for BPDCN in elderly transplant-ineligible patients and the emerging BPDCN research and data that they are most interested in to improve outcomes in this specific patient population.
Latest:
Mapping ctDNA Shedding Differences in GU Cancers With MRD TestingArnab Basu, MD, MPH, FACP, explains why sensitivity might be higher in urothelial cancer vs other genitourinary cancers.
Latest:
Unmet Needs and Future Directions for Ovarian CancerThomas C. Krivak MD, John K. Chan, MD, and Cecelia H. Boardman, MD, share insight on recent updates to maintenance therapy, unmet needs, and the future treatment landscape for ovarian cancer.
Latest:
Ongoing Research in Brain Tumor Therapies Provides Hope for the FuturePrimary brain cancers are aggressive, resulting in low survival rates, and pose significant challenges to effective treatment, but ongoing studies signal hope for patients with there tumors.
Latest:
EP. 2B: The Impact of Updated Sub-Analysis Data on the Role of Larotrectinib for NTRK Fusion-positive Thyroid CancerIn the first interview of this series, Steven G. Waguespack, MD, considers long-term safety and efficacy data on larotrectinib and discusses implications for the treatment landscape for NTRK fusion-positive thyroid cancer.
Latest:
Exploring the Design of the ECOG-ACRIN E1411 Trial in MCLMitchell Smith, MD, PhD, discusses the ECOG-ACRIN E1411 trial among patients with previously untreated mantle cell lymphoma.
Latest:
Unpacking the Latest Research in Gastrointestinal CancersIn season 4, episode 1 of Targeted Talks, Benjamin L. Schlechter, MD, discuses new studies in the gastrointestinal cancers space.
Latest:
Treatment Research Landscape in Chronic Lymphocytic LeukemiaJohn Allan, MD, provides insights on novel agents and treatment strategies currently being studied in chronic lymphocytic leukemia.
Latest:
New Pharmacological Frontiers in Neuroendocrine Cancer TreatmentFrom precision radiotherapeutics to small molecule inhibitors, Scott Paulson, MD, discusses a new array of pharmacological treatments for World Neuroendocrine Cancer Day.
Latest:
No-Shave November: The Benefits of the Transperineal Versus Transrectal Approach to Prostate Cancer BiopsyMatthew J. Allaway, DO, discusses the need for a safe, precise and efficient option for performing prostate cancer biopsies via the transperineal approach and the limitations with the current standard of care, which is the transrectal approach, during No-Shave November awareness month.
Latest:
NATALEE Trial Evaluates Ribociclib With ET in Early Breast CancerGabriel N. Hortabagyi, MD, FACP, provides an overview of the phase 3 NATALEE trial evaluating the combination of ribociclib with endocrine therapy as adjuvant treatment in patients with hormone receptor-positive/HER2-negative early breast cancer.
Latest:
Exploring Neoadjuvant Treatment in NSCLCBenny Weskler, MBA, MD, FACS, FACCP, discusses the introduction of immune checkpoint inhibitors in the neoadjuvant setting for patients with non–small cell lung cancer.
Latest:
HER2CLIMB-02 Trial to Assess Tucatinib and T-DM1 in HER2+ Breast CancerGiuseppe Curigliano, MD, discussed next steps following the HER2CLIMB study in HER2-positive breast cancer.
Latest:
Novel Therapies in Development for Myelofibrosis Show PromiseSrdan Verstovsek, MD, PhD, highlighted recent advancements in developing novel therapeutic strategies for myelofibrosis during SOHO 2022.
Latest:
Buprenorphine for Refractory Pain in Patients Undergoing Bone Marrow TransplantMayuko Sakae, MD, discusses findings from research presented at the 2024 Multinational Association of Supportive Care in Cancer Annual Meeting on refractory pain in patients who have undergone a bone marrow transplant.
Latest:
The Journey to Holistic Care for Childhood Cancer PatientsAs oncologists and the healthcare industry advance their practices to propel care for children, it is crucial for the industry and population at large to tailor care for the unique needs of children to maximize recovery and truly help patients thrive.
Latest:
What to Know About the Phase 2 ARCITECT Trial in ccRCCMichael Serzan, MD, discusses what a community oncologist should know about the phase 2 ARCITECT trial for patients with clear cell renal cell carcinoma.
Latest:
Results Demonstrate Accuracy of the 68Ga-PSMA-11 PET for Prostate CancerThomas Hope, MD, discusses the efficacy of the 68Ga-PSMA-11 PET for the detection of pelvic nodal metastases in patients intermediate- to high-risk prostate cancer considered for radical prostatectomy with lymph node dissection.
Latest:
Current and Emerging Developments for the Treatment of Endometrial CancerWesley Burkett, MD, discusses some novel targets that are available and being evaluated in the endometrial cancer space.
Latest:
Stratifying Patients With Pediatric Versus Adult Thyroid CancerAime T. Franco, PhD, discusses how recent research has explored the difference between pediatric thyroid cancer and adult thyroid cancer at the 91st Annual Meeting of the American Thyroid Association.
